BVS FY 2021 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

FY 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$431M+34.2% YoY

Gross Profit

$303M70.3% margin

Operating Income

$12M2.8% margin

Net Income

$19M4.5% margin

EPS (Diluted)

$-0.15

Cash Flow

Operating Cash Flow

$23M

Free Cash Flow

$2M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$692M

Stockholders' Equity

$459M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$431M	$321M	+34.2%
Gross Profit	$303M	$234M	+29.6%
Operating Income	$12M	$21M	-43.2%
Net Income	$19M	$16M	+18.1%